In an ever-evolving technological landscape, optimizing IT service management becomes a crucial undertaking for organizations seeking operational excellence. Darnytsia Pharmaceutical Company, top Ukrainian pharmaceutical company, recognized the need to streamline its IT processes and enhance IT service delivery. To address these challenges, Darnytsia partnered with Treran Systems, solutions provider, to implement Combodo iTop ITSM solution.
Darnytsa faced several challenges in its IT operations, ranging from inefficiencies within the IT department to the lack of a unified repository for IT-related information.
Treran Systems undertook a comprehensive approach to address Darnytsia business challenges. The Combodo iTop ITSM solution, version 3.0, was selected due to its robust features and customization capabilities. Deployment conducted on customer’s premises. The key components of the solution were developed by Treran Systems within 6 months timeline with post-launch support and further enhancements handling.
The deployment of iTop ITSM solution had a profound impact on Darnytsia Pharmaceutical Company:
It was a successful journey, we are happy to have Treran team as a reliable partner throughout our implementation journey.
Treran Systems successfully implemented the Combodo iTop ITSM solution at Darnytsia Pharmaceutical Company, resolving critical business challenges and transforming IT operations. The deployment of iTop v.3.0 resulted in enhanced efficiency, unified data access, improved knowledge management, streamlined helpdesk operations, data-driven decision-making, optimized CMDB management, proactive service monitoring, standardized workflows, and an enhanced user experience. With a dedicated approach and a comprehensive suite of ITSM solutions, Treran Systems propelled Darnytsia towards operational excellence and technological advancement.
Darnytsia is a pharmaceutical company, headquartered in Kyiv, Ukraine, stands as one of the leading pharmaceutical entities in the Central and Eastern European region.
With a rich history spanning over 90 years, the company offers a wide product portfolio that comprises around 250 medicinal products, catering to various therapeutic areas such as cardiology, neurology, gastroenterology and pain management.
Having a vast domestic distribution network and exporting to over 60 countries, the company established a formidable international presence. In recent years, Darnytsia has demonstrated a notable financial performance and stability, showcasing a steady growth trajectory which is partially attributed to its strategic expansions and acquisitions.
“MHP”